Topical application of antiangiogenic agent AGM-1470 suppresses anastomotic intimal hyperplasia after ePTFE grafting in a rabbit model
- 1 February 2001
- Vol. 129 (2) , 220-230
- https://doi.org/10.1067/msy.2001.110769
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 33 references indexed in Scilit:
- Inhibition of vein graft intimal and medial thickening by periadventitial application of a sulfated carbohydrate polymerJournal of Vascular Surgery, 1996
- Determination of O‐(chloroacetylcarbamoyl)fumagillol (TNP‐470; AGM‐1470) and two metabolites in plasma by high‐performance liquid chromatography/mass spectrometry with atmospheric pressure chemical ionizationJournal of Mass Spectrometry, 1995
- Pathobiology of intimal hyperplasiaBritish Journal of Surgery, 1994
- Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.Journal of Clinical Investigation, 1994
- Suppression of Neointimal Smooth Muscle Cell Accumulation in Vivo by Antisense cdc2 and cdk2 Oligonucleotides in Rat Carotid ArteryBiochemical and Biophysical Research Communications, 1994
- Angiopeptin as a Potent Inhibitor of Myointimal HyperplasiaAsaio Journal, 1993
- Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivoNature, 1993
- Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Atherosclerosis in rabbit vein grafts.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989